Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Polyps 1Lymphoma, Follicular 1Huntington Disease 1Fatigue 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Exercise 34Therapeutics 22Modafinil 21Yoga 17Methylphenidate 16Psychiatric Rehabilitation 11Acupuncture Therapy 11Surveys and Questionnaires 10Educational Status 9Walking 8Early Intervention, Educational 8Cognitive Behavioral Therapy 8Ultraviolet Therapy 7Control Groups 7Therapeutic Touch 6Physical Therapy Modalities 6Exercise Therapy 6Acceptance and Commitment Therapy 6Sugars 5Qigong 5Counseling 5Standard of Care 4Saline Solution 4Palliative Care 4Methods 4Epoetin Alfa 4Dexamethasone 4Behavior Therapy 4Acupressure 4methyl hydroxyethyl cellulose 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fatigue × eicosapentaenoic acid ethyl ester × Clear all
NCT02940223 2021-06-10

Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
2 enrolled 6 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡